Comparing Semler Scientific (NASDAQ:SMLR) & Gadsden Properties (OTCMKTS:GADS)

Gadsden Properties (OTCMKTS:GADS) and Semler Scientific (NASDAQ:SMLR) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

Insider & Institutional Ownership

49.4% of Semler Scientific shares are owned by institutional investors. 5.0% of Gadsden Properties shares are owned by company insiders. Comparatively, 30.2% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Gadsden Properties and Semler Scientific”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gadsden Properties	N/A	N/A	N/A	N/A	N/A
Semler Scientific	$56.29 million	6.28	$20.58 million	$4.91	7.50

Semler Scientific has higher revenue and earnings than Gadsden Properties.

Analyst Ratings

This is a breakdown of current recommendations for Gadsden Properties and Semler Scientific, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gadsden Properties	0	0	0	0	0.00
Semler Scientific	0	0	1	0	3.00

Semler Scientific has a consensus target price of $71.00, indicating a potential upside of 92.73%. Given Semler Scientific’s stronger consensus rating and higher probable upside, analysts plainly believe Semler Scientific is more favorable than Gadsden Properties.

Risk and Volatility

Gadsden Properties has a beta of -6.66, indicating that its share price is 766% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500.

Profitability

This table compares Gadsden Properties and Semler Scientific’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Gadsden Properties	N/A	N/A	N/A
Semler Scientific	72.65%	50.77%	47.04%

Summary

Semler Scientific beats Gadsden Properties on 10 of the 10 factors compared between the two stocks.

About Gadsden Properties

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.

About Semler Scientific

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.